Josh Gottheimer sold Novanta Inc (NASDAQ: NOVT)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 1 trade in Novanta Inc (NOVT) since 2022, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Josh Gottheimer sold $1,001 - $15,000 of Novanta Inc (NASDAQ: NOVT) on July 25, 2022. Since that trade, NOVT is down -6.19% against the S&P 500 up +97.30%, an outperformance of -103.49%.
Data updated
Josh Gottheimer's NOVT trades vs the price
NOVT is down -6.19% since Josh Gottheimer sold on July 25, 2022, versus +97.30% for the S&P 500.
Performance since this trade
All Josh Gottheimer NOVT trades
Josh Gottheimer & NOVT trading FAQ
Is it legal for Josh Gottheimer to trade Novanta Inc (NOVT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novanta Inc (NOVT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer sell NOVT?
Josh Gottheimer disclosed a sale of $1,001 - $15,000 of Novanta Inc (NOVT) on July 25, 2022, according to public STOCK Act filings.
How has NOVT performed since Josh Gottheimer's trade?
Since Josh Gottheimer sold NOVT on July 25, 2022, the stock is down -6.19%, versus +97.30% for the S&P 500 over the same period, an outperformance of -103.49%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NOVT trades?
Quantellect tracks every disclosed congressional trade in Novanta Inc (NOVT) on the Novanta Inc congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's NOVT tradesAll congressional filings for Novanta IncJosh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.